G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor

Circulation

Volumn 111, Issue 14, 2005, Pages 1806-1813

  Kostenis, Evi ^a   Milligan, Graeme ^b   Christopoulos, Arthur ^c   Sanchez Ferrer, Carlos F ^d   Heringer Walther, Silvia ^e   Sexton, Patrick M ^c   Gembardt, Florian ^e,f   Kellett, Elaine ^b   Martini, Lene ^a   Vanderheyden, Patrick ^g   Schultheiss, Heinz Peter ^f   Walther, Thomas ^e,f  

^a 7TM Pharma ^*  (Denmark)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Angiotensin; Calcium; Muscle, smooth; Receptors; Vasoconstriction

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR MAS; INOSITOL PHOSPHATE; LOSARTAN; OLIGOMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENTERIC ARTERY; MOUSE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CALCIUM; CHO CELLS; CRICETINAE; INOSITOL PHOSPHATES; MESENTERIC ARTERIES; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; TRANSFECTION; VASOCONSTRICTION;

EID: 20244388129     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000160867.23556.7D     Document Type: Article

References (27)

1. Young D, Waitches G, Birchmeier C, Fasano O, Wigler M. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell. 1986;45:711-719.
2. Bunnemann B, Fuxe K, Metzger R, Mullins J, Jackson TR, Hanley MR, Ganten D. Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization. Neurosci Lett. 1990;114:147-153.
3. Alenina N, Bader M, Walther T. Imprinting of the murine MAS protooncogene is restricted to its antisense RNA. Biochem Biophys Res Commun. 2002;290:1072-1078.
4. Jackson TR, Blair LA, Marshall J, Goedert M, Hanley MR. The mas oncogene encodes an angiotensin receptor. Nature. 1988;335:437-440.
5. Ambroz C, Clark A, Catt KJ. The mas oncogene enhances angiotensin-induced [Ca2+]i responses in cells with pre-existing angiotensin II receptors. Biochim Biophys Acta. 1991;1133:107-111.
6. Ardaillou R. Angiotensin II receptors. J Am Soc Nephrol. 1999;10(suppl 11):S30-S39.
7. Von Bohlen und Halbach O, Walther T, Bader M, Albrecht D. Interaction between Mas and the angiotensin AT1 receptor in the amygdala. J Neurophysiol. 2000;83:2012-2021.
8. Walther T, Balschun D, Voigt JP, Fink H, Zuschratter W, Birchmeier C, Ganten D, Bader M. Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene. J Biol Chem. 1998;273:11867-11873.
9. Walther T, Voigt JP, Fink H, Bader M. Sex specific behavioural alterations in Mas-deficient mice. Behav Brain Res. 2000;107:105-109.
10. Ferrario CM, Chappell MC, Dean RH, Iyer SN. Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis. J Am Soc Nephrol. 1998;9:1716-1722.
11. Santos R, Simoes e Silva A, Maric C, Silva D, Machado R, de Buhr I, Heringer-Walther S, Pinheiro S, Lopes M, Bader M, Mendes E, Lemos V, Campagnole-Santos M, Schultheiss H-P, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A. 2003;100:8258-8263.
12. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science. 2000;288:154-157.
13. Galvez T, Duthey B, Kniazeff J, Blahos J, Rovelli G, Bettler B, Prezeau L, Pin JP. Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function. EMBO J. 2001;20:2152-2159.
14. Milligan G. Oligomerisation of G-protein-coupled receptors. J Cell Sci. 2001;114:1265-1271.
15. AbdAlla S, Lother H, Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature. 2000;407:94-98.
16. AbdAlla S, Lother H, el Massiery A, Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med. 2001;7:1003-1009.
17. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem. 2001;276:39721-39726.
18. Heydorn A, Ward RJ, Jorgensen R, Rosenkilde MM, Frimurer TM, Milligan G, Kostenis E. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction. Mol Pharmacol 2004;66:250-259.
19. Ramsay D, Kellett E, McVey M, Rees S, Milligan G. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem J. 2002;365:429-440.
20. Mulvany M, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
21. Salim K, Fenton T, Bacha J, Urien-Rodriguez H, Bonnert T, Skynner HA, Watts E, Kerby J, Heald A, Beer M, McAllister G, Guest PC. Oligomerization of G-protein-coupled receptors shown by selective coimmunoprecipitation. J Biol Chem. 2002;277:15482-15485.
22. Rodríguez-Mañas L, Angulo J, Peiró C, Llergo JL, Sánchez-Ferrer A, López-Dóriga P, Sánchez-Ferrer CF. Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats. Br J Pharmacol. 1998;123:1495-1502.
23. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci U S A. 2001;98:343-348.
24. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A. 2000;97:3684-3689.
25. McVey M, Ramsay D, Kellett E, Rees S, Wilson S, Pope AJ, Milligan G. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer: the human delta-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J Biol Chem. 2001;276:14092- 14099.
26. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci. 2001;2:274-286.
27. Mercier JF, Salahpour A, Angers S, Breit A, Bouvier M. Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem. 2002;277:44925-44931.